Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Laboratory Testing Platform for Vitamin D Assay Validated

By LabMedica International staff writers
Posted on 20 Jul 2012
AACC 2012: The quality of Vitamin D assays was demonstrated based on performance metrics.

With a simple blood test, the Architect 25-OH Vitamin D assay can measure the stable form of Vitamin D (also known as 25-hydroxyvitamin D), which is the body’s repository of Vitamin D. More...


The Architect 25-OH Vitamin D assay by Abbott (Abbott Park, IL, USA) is a chemiluminescent microparticle immunoassay (CMIA), for the quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D) in human serum and plasma. The Architect 25-OH Vitamin D assay is to be used as an aid in the assessment of vitamin D sufficiency. It is recommended that each laboratory establish its own reference range. Results should be used in conjunction with other data such as symptoms, results of other tests, clinical impressions.

The Vitamin D assay contains method variations; therefore, it is important to apply standardized quality metrics to quality control so that clinicians are confident that they can rely on test results.

A quality-management methodology called Six Sigma was applied by Abbott to its Vitamin D assay to quantify and improve the performance of the lab process and increase the accuracy and reliability of test results.

Mr. Westgard, an expert on quality control and method validation, and an instructor at the Mayo School of Health Sciences, presented on the panel Vitamin D Testing on Wednesday, July 18, 2012, at the American Association for Clinical Chemistry (AACC) Annual Meeting in Los Angeles (CA, USA). He described how the performance of automated 25-OH vitamin D immunoassays was compared to Liquid Chromatography–Mass Spectrometry (LC-MS) techniques.

Sten Westgard, director of client services and technology, Westgard QC, Inc., commented, "Six Sigma provides an objective tool for assessment of laboratory processes, along with quality requirements and performance data. Based on benchmarking evaluation using Sigma metrics, the Abbott ARCHITECT system has demonstrated a range of performance from excellent to world class.

Related Links:
Abbott





Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.